Decreases the activity of TAM and CD8+ T cells. Induce the expression of Th2 cytokines modulating the antitumor immune response. Induce a regulatory phenotype on NK cells by modulating DCs. Stimulates the growth of tumor cells and cell death resistance. The gene discussed is CD8A; the disease is neoplasm.